Mark J. Scharf

990 total citations · 1 hit paper
8 papers, 628 citations indexed

About

Mark J. Scharf is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, Mark J. Scharf has authored 8 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Dermatology and 2 papers in Epidemiology. Recurrent topics in Mark J. Scharf's work include Autoimmune Bullous Skin Diseases (2 papers), Oral Health Pathology and Treatment (1 paper) and Porphyrin Metabolism and Disorders (1 paper). Mark J. Scharf is often cited by papers focused on Autoimmune Bullous Skin Diseases (2 papers), Oral Health Pathology and Treatment (1 paper) and Porphyrin Metabolism and Disorders (1 paper). Mark J. Scharf collaborates with scholars based in United States. Mark J. Scharf's co-authors include David W. Hosmer, Jeffrey D. Bernhard, Jon Kabat‐Zinn, Timothy Light, Thomas G. Cropley, Tatyana R. Humphreys, Sue M. Marcus, Rajwant Malhotra, Karen Wiss and Shinya Amano and has published in prestigious journals such as Journal of the American Academy of Dermatology, Psychosomatic Medicine and Dermatologic Therapy.

In The Last Decade

Mark J. Scharf

6 papers receiving 547 citations

Hit Papers

Influence of a Mindfulness Meditation-Based Stress Reduct... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Scharf United States 4 362 126 112 111 94 8 628
Cheryl M. Paradis United States 14 283 0.8× 75 0.6× 216 1.9× 24 0.2× 118 1.3× 29 613
Marjorie Hatch United States 9 123 0.3× 77 0.6× 107 1.0× 23 0.2× 53 0.6× 11 311
Christina Schut Germany 15 90 0.2× 472 3.7× 30 0.3× 77 0.7× 31 0.3× 41 662
Burkhard Brosig Germany 14 199 0.5× 133 1.1× 61 0.5× 14 0.1× 52 0.6× 70 585
Madhulika A. Gupta Canada 10 250 0.7× 363 2.9× 48 0.4× 31 0.3× 7 0.1× 12 667
Rama Malhotra India 13 140 0.4× 129 1.0× 16 0.1× 15 0.1× 89 0.9× 18 588
C. Gala Italy 9 343 0.9× 33 0.3× 149 1.3× 10 0.1× 124 1.3× 10 773
Mary R. Haynes United States 15 206 0.6× 109 0.9× 54 0.5× 35 0.3× 58 0.6× 21 661
Alasdair L. Henry United Kingdom 15 87 0.2× 95 0.8× 537 4.8× 21 0.2× 38 0.4× 36 832
Paul D’Alton Ireland 10 127 0.4× 22 0.2× 19 0.2× 48 0.4× 123 1.3× 33 401

Countries citing papers authored by Mark J. Scharf

Since Specialization
Citations

This map shows the geographic impact of Mark J. Scharf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Scharf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Scharf more than expected).

Fields of papers citing papers by Mark J. Scharf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Scharf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Scharf. The network helps show where Mark J. Scharf may publish in the future.

Co-authorship network of co-authors of Mark J. Scharf

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Scharf. A scholar is included among the top collaborators of Mark J. Scharf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Scharf. Mark J. Scharf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Orlowski, Gregory M., et al.. (2020). Primary cutaneous nasal-type NK/T-cell lymphoma presenting as purpuric nodules on the lower leg. JAAD Case Reports. 6(10). 1075–1078.
2.
Amano, Shinya, et al.. (2020). Porphyria cutanea tarda associated with nitrofurantoin: A unique drug reaction. Dermatologic Therapy. 33(6). e14026–e14026. 1 indexed citations
3.
Lee, Jennifer W., et al.. (2016). Cutaneous pemphigus vegetans co-occurring with oral pemphigus vulgaris. Journal of the American Academy of Dermatology. 74(5). AB49–AB49.
4.
Scharf, Mark J., et al.. (2012). Imiquimod reactivation of lichen planus.. PubMed. 89(6). 276–7, 283. 17 indexed citations
5.
Scharf, Mark J.. (2002). Cutaneous injuries and envenomations from fish, sharks and rays. Dermatologic Therapy. 15(1). 47–57. 11 indexed citations
6.
Kabat‐Zinn, Jon, Timothy Light, Mark J. Scharf, et al.. (1998). Influence of a Mindfulness Meditation-Based Stress Reduction Intervention on Rates of Skin Clearing in Patients With Moderate to Severe Psoriasis Undergoing Photo Therapy (UVB) and Photochemotherapy (PUVA). Psychosomatic Medicine. 60(5). 625–632. 522 indexed citations breakdown →
7.
Humphreys, Tatyana R., et al.. (1998). Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ With a High-Energy Pulsed Carbon Dioxide Laser. Archives of Dermatology. 134(10). 1247–52. 76 indexed citations
8.
Merin, Gideon, et al.. (1985). Rupture of splenic abscess through the diaphragm.. PubMed. 21(4). 370–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026